Literature DB >> 12712971

Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.

Wilma Basualdo1, Antonio Arbo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12712971

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  12 in total

1.  Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States.

Authors:  Maria Sjölund Karlsson; Anna Bowen; Roshan Reporter; Jason P Folster; Julian E Grass; Rebecca L Howie; Julia Taylor; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

2.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

3.  Options for treating resistant Shigella species infections in children.

Authors:  Sharon M Erdman; Elizabeth E Buckner; Janet F Hindler
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

Review 4.  Antibiotic therapy for Shigella dysentery.

Authors:  Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

5.  Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection.

Authors:  Jennifer P Collins; Cindy R Friedman; Meseret G Birhane; Beth E Karp; Anthony Osinski; Mary W Montgomery; Deepam Thomas; Jonathan Barkley; Martha C Sanchez; Samir Hanna; Azizat A Adediran; Jessica C Chen; Hayat Caidi; Louise Francois Watkins
Journal:  Open Forum Infect Dis       Date:  2020-04-18       Impact factor: 3.835

6.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

7.  Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.

Authors:  Radhika Gharpure; Cindy R Friedman; Veronica Fialkowski; Jennifer P Collins; Jonathan Strysko; Zachary A Marsh; Jessica C Chen; Elizabeth H Meservey; Azizat A Adediran; Morgan N Schroeder; Ashutosh Wadhwa; Kathleen E Fullerton; Louise Francois Watkins
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

8.  Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.

Authors:  Mahbubur Rahman; Shereen Shoma; Harunur Rashid; Shams El Arifeen; A H Baqui; A K Siddique; G B Nair; D A Sack
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

9.  Use of population-based surveillance to define the high incidence of shigellosis in an urban slum in Nairobi, Kenya.

Authors:  Henry N Njuguna; Leonard Cosmas; John Williamson; Dhillon Nyachieo; Beatrice Olack; John B Ochieng; Newton Wamola; Joseph O Oundo; Daniel R Feikin; Eric D Mintz; Robert F Breiman
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Azithromycin Resistance in Shigella spp. in Southeast Asia.

Authors:  Thomas C Darton; Ha Thanh Tuyen; Hao Chung The; Paul N Newton; David A B Dance; Rattanaphone Phetsouvanh; Viengmon Davong; James I Campbell; Nguyen Van Minh Hoang; Guy E Thwaites; Christopher M Parry; Duy Pham Thanh; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.938
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.